Heidelberg Pharma AG

Declaration of Voting Results & Voting Rights Announcements • Sep 5, 2012

News Details

Voting Rights Announcements | 5 September 2012 12:20

WILEX AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

WILEX AG

05.09.2012 12:20

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

WILEX AG, Grillparzerstr. 10, 81675 Munich, Germany (WKN 661472, ISIN
DE0006614720 respectively) has received on 31 August 2012 (corrected on 4
September 2012) the following voting rights announcement pursuant to
Section 21 para. 1 of the Securities Trading Act [Wertpapierhandelsgesetz;
WpHG]:

1. On 27 August 2012, the voting interest held by UCB Pharma S.A.,
   Brussels, Belgium, in WILEX AG, Munich, Germany, fell below the threshold
   of 15 % and amounted to 14.47% (4,524,743 voting rights of a total of
   31,275,507 voting rights). On 27 August 2012 3,899,639 voting rights and
   the underlying shares (12,47%) were directly held by UCB Pharma S.A. and
   625,104 voting rights and the underlying shares (2,00%) were attributed to
   UCB Pharma S.A. pursuant to Section 22 para 1 sentence 1 no. 2 Securities
   Trading Act. On 28 August 2012 after settlement of the capital increase all
   4,524,743 (14,47%) voting rights and the underlying shares were directly
   held by UCB Pharma S.A.

2. On 27 August 2012, the voting interest held by UCB S.A., Brussels,
   Belgium, in WILEX AG, Munich, Germany, fell below the threshold of 15% and
   amounted to 14.47% (4,524,743 voting rights of a total of 31,275,507 voting
   rights). On 27 August 2012 3,899,639 voting rights (12,47%) were attributed
   to UCB S.A. pursuant to Section 22 para 1 sentence 1 no. 1 Securities
   Trading Act by UCB Pharma S.A and 625,104 voting rights (2,00%) were
   attributed to UCB S.A. pursuant to Section 22 para 1 sentence 1 no. 2 in
   connection with sentence 2 Securities Trading Act. On 28 August 2012 after
   settlement of the capital increase all 4,524,743 voting rights (14,47%)
   were attributed to UCB S.A. pursuant to Section 22 para 1 sentence 1 no. 1
   Securities Trading Act by UCB Pharma S.A.

3. On 27 August 2012, the voting interest held by Financière de Tubize
   S.A., Brussels, Belgium, in WILEX AG, Munich, Germany, fell below the
   threshold of 15% and amounted to 14.47% (4,524,743 voting rights of a total
   of 31,275,507 voting rights). On 27 August 2012 3,899,639 voting rights
   (12,47%) were attributed to Financière de Tubize S.A. pursuant to Section
   22 para 1 sentence 1 no. 1 of the Securities Trading Act by UCB S.A. and
   UCB Pharma S.A and 625,104 voting rights (2,00%) were attributed to
   Financière de Tubize S.A. pursuant to Section 22 para 1 sentence 1 no. 2 in
   connection with sentence 2 Securities Trading Act. On 28 August 2012 after
   settlement of the capital increase all 4,524,743 voting rights (14,47%)
   were attributed to Financière de Tubize S.A. pursuant to Section 22 para 1
   sentence 1 no. 1 of the Securities Trading Act by UCB S.A. and UCB Pharma
   S.A.

Munich, 5 September 2012

WILEX AG
Executive Management Board

05.09.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language: English
Company: WILEX AG
Grillparzerstr. 10
81675 München
Germany
Internet: www.wilex.com

End of Announcement DGAP News-Service

---